Studies have shown that active fund managers routinely underperform the S&P500 index*​

Edwards Lifesciences Corporation (NYSE: EW)

EW Stock Predictions and Ratings

WSX Rating:
HOLD
WSX Forecast (1yr):
1.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
20.20%

EW Stock Analysis

EW PE Ratio: 45.7

EW PEG Ratio: 3.8

EW Forward EPS Growth (12 month): 11.90%

EW PS Ratio: 7.9

EW PSG Ratio: 0.8

EW Forward Revenue Growth (12 month): 9.90%

EW Articles

No data was found